Unclear Regulatory Expectations for New Tech? FDA and EMA Perspectives
Addressing Regulatory Ambiguities in Emerging Technologies: Insights from the FDA and EMA In the rapidly evolving landscape of pharmaceutical manufacturing, organizations often grapple with unclear regulatory expectations regarding new technologies.…